scholarly journals Vitamin B12 and Risk of Diabetes: New Insight from Cross-Sectional and Longitudinal Analyses of the China Stroke Primary Prevention Trial (CSPPT)

2020 ◽  
Author(s):  
Lishun Liu ◽  
Xiao Huang ◽  
Binyan Wang ◽  
Yun Song ◽  
Tengfei Lin ◽  
...  
Keyword(s):  
Primary Prevention ◽  
Vitamin B12 ◽  
Prevention Trial ◽  
Longitudinal Analyses ◽  
Primary Prevention Trial ◽  
Cross Sectional

scholarly journals Vitamin B12 and risk of diabetes: new insight from cross-sectional and longitudinal analyses of the China Stroke Primary Prevention Trial (CSPPT)

2020 ◽  
Vol 8 (1) ◽  
pp. e001423
Author(s):  
Lishun Liu ◽  
Xiao Huang ◽  
Binyan Wang ◽  
Yun Song ◽  
Tengfei Lin ◽  
...  
Keyword(s):  
Primary Prevention ◽  
Positive Association ◽  
Prevention Trial ◽  
Vitamin B ◽  
Longitudinal Analyses ◽  
Primary Prevention Trial ◽  
Cross Sectional ◽  
Onset Diabetes ◽  
New Onset

IntroductionPrevious studies in mostly Western populations have yielded conflicting findings on the association of vitamin B12 with diabetes risk, in part due to differences in study design and population characteristics. This study sought to examine the vitamin B12–diabetes association in Chinese adults with hypertension by both cross-sectional and longitudinal analyses.Research design and methodsThis report included a total of 16 699 participants from the China Stroke Primary Prevention Trial, with pertinent baseline and follow-up data. Diabetes mellitus was defined as either physician-diagnosed diabetes, use of glucose-lowering drugs, or fasting blood glucose (FBG) ≥7.0 mmol/L. New-onset diabetes was defined as any new case of onset diabetes during the follow-up period or FBG ≥7.0 mmol/L at the exit visit.ResultsAt baseline, there were 1872 (11.2%) patients with diabetes; less than 1.5% had clinical vitamin B12 deficiency (<148.0 pmol/L). Over a median follow-up period of 4.5 years, there were 1589 (10.7%) cases of new-onset diabetes. Cross-sectional analyses showed a positive association between baseline vitamin B12 levels and FBG levels (β=0.18, 95% CI 0.15 to 0.21) and diabetes (OR=1.16, 95% CI 1.10 to 1.21). However, longitudinal analyses showed no association between baseline vitamin B12 and new-onset diabetes or changes in FBG levels. Among a subset of the sample (n=4366) with both baseline and exit vitamin B12 measurements, we found a positive association between an increase in vitamin B12 and an increase in FBG.ConclusionsIn this large Chinese population of patients with hypertension mostly sufficient with vitamin B12, parallel cross-sectional and longitudinal analyses provided new insight into the conflicting findings of previous studies, and these results underscore the need for future studies to consider both baseline vitamin B12 and its longitudinal trajectory in order to better elucidate the role of vitamin B12 in the development of diabetes. Such findings would have important clinical and public health implications.

scholarly journals Vitamin B12 and Risk of Diabetes: New insight from Cross-Sectional and Longitudinal Analyses of the China Stroke Primary Prevention Trial (CSPPT)

2020 ◽  
Author(s):  
Lishun Liu ◽  
Xiao Huang ◽  
Binyan Wang ◽  
Yun Song ◽  
Tengfei Lin ◽  
...  
Keyword(s):  
Blood Glucose ◽  
Vitamin B12 ◽  
Fasting Blood Glucose ◽  
Positive Association ◽  
Longitudinal Analyses ◽  
Primary Prevention Trial ◽  
Cross Sectional ◽  
Onset Diabetes ◽  
New Onset

AbstractIntroductionPrevious studies in mostly Western populations, have yielded conflicting findings on the association of vitamin B12 with diabetes risk, in part, due to differences in study design and population characteristics. This study sought to examine the vitamin B12 – diabetes association in Chinese hypertensive adults by both cross-sectional and longitudinal analyses.Research Design and MethodsThis report included a total of 16699 participants from the China Stroke Primary Prevention Trial (CSPPT), with pertinent baseline and follow-up data. Diabetes mellitus (DM) was defined as either physician-diagnosed diabetes, the use of glucose-lowering drugs, or fasting blood glucose (FBG) ≥7.0 mmol/L. New-onset diabetes was defined as any new case of onset diabetes during the follow-up period or fasting blood glucose (FBG) ≥7.0 mmol/L at the exit visit.ResultsAt baseline, there were 1872 (11.2%) diabetic patients; less than 1.5% had clinical B12 deficiency (<148.0 pmol/L). Over a median follow-up period of 4.5 years, there were 1589 (10.7%) cases of new-onset diabetes. Cross-sectional analyses showed a positive association between baseline vitamin B12 levels and FBG levels (β=0.18, 95%CI 0.15-0.21) and diabetes (OR=1.42, 95%CI 1.33-1.51). However, longitudinal analyses showed no association between baseline vitamin B12 and new-onset diabetes or changes in FBG levels. Among a subset of the sample (N=4366) with both baseline and exit B12 measurements, we found a positive association between an increase in B12 and an increase in FBG.ConclusionsIn this large Chinese hypertensive population mostly sufficient with vitamin B12, parallel cross-sectional and longitudinal analyses provided new insight into the conflicting findings of previous studies, and these results underscore the need for future studies to consider both baseline vitamin B12 and its longitudinal trajectory in order to better elucidate the role of vitamin B12 in the development of diabetes. Such findings, would have important clinical and public health implications.

Sign in / Sign up

Export Citation Format

Share Document